ArronK, OliverC, MossJ, BergK, BurbidgeC: The prevalence and phenomenology of self-injurious and aggressive behaviour in genetic syndromes. J Intellect Disabil Res, 55:109–20, 2011.
2.
BalldinJ, BerggrenU, ErikssonE, LindstedtG, SundklerA: Guanfacine as an alpha-2-agonist inducer of growth hormone secretion––a comparison with clonidine. Psychoneuroendocrinology, 18:45–55, 1993.
3.
BeyazyüzM, AlbayrakY, EğilmezOB, AlbayrakN, BeyazyüzE: Relationship between SSRIs and metabolic syndrome abnormalities in patients with generalized anxiety disorder: A Prospective study. Psychiatry Investig, 10:148–154, 2013.
4.
CatalettoM, AnguloM, HertzG, WhitmanB:Prader–Willi syndrome: A primer for clinicians. Int J Pediatr Endocrinol, 2011:12, 2011.
5.
CopetP, JauregiJ, LaurierV, EhlingerV, ArnaudC, CoboAM, MolinasC, TauberM, ThuilleauxD: Cognitive profile in a large French cohort of adults with Prader–Willi syndrome: Differences between genotypes. J Intellect Disabil Res, 54:204–215, 2010.
6.
DykensE, ShahB: Psychiatric disorders in Prader–Willi syndrome: Epidemiology and management. CNS Drugs, 17:167–178, 2003.
HergünerS, MukaddesNM: Psychosis associated with fluoxetine in Prader–Willi syndrome. J Am Acad Child Adolesc Psychiatry, 46:944–945, 2007.
10.
KaySR, WolkenfeldF, MurrillLM: Profiles of aggression among psychiatric patients. I. Nature and prevalence. J Nerv Ment Dis, 176:539–546, 1988.
11.
KohnY, WeizmanA, ApterA: Aggravation of food-related behavior in an adolescent with Prader–Willi syndrome treated with fluvoxamine and fluoxetine. Int J Eat Disord, 30:113–117, 2001.
12.
MaX, MaimaitirexiatiT, ZhangR, GuiX, ZhangW, XuG, HuG: HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: A meta-analysis. Int J Psychiatry Clin Pract, 18:1–14, 2014.
RuggieroS, ClavennaA, RealeL, CapuanoA, RossiF, BonatiM: Guanfacine for attention deficit and hyperactivity disorder in pediatrics: A systematic review and meta-analysis. Eur Neuropsychopharmacol, 24:1578–1590, 2014.
15.
SchulzKP, ClerkinSM, FanJ, HalperinJM, NewcornJH: Guanfacine modulates the influence of emotional cues on prefrontal cortex activation for cognitive control. Psychopharmacology, 226:261–271, 2013.
16.
WigrenM, HansenS: ADHD symptoms and insistence on sameness in Prader–Willi syndrome. J Intellect Disabil Res, 49:449–456, 2005.
